Growing up With the Young Endocrine Support System (YESS!)

Sponsor
dr. Laura C. G. de Graaff-Herder (Other)
Overall Status
Not yet recruiting
CT.gov ID
NCT04252001
Collaborator
(none)
160
7
4
36
22.9
0.6

Study Details

Study Description

Brief Summary

Transition from paediatric to adult endocrinology is a challenge for adolescents, families and doctors. Up to 25% of young adults with chronic endocrine disorders are lost to follow-up ('drop-out') once the young adult moves out of paediatric care. Non-attendance and sub-optimal medical self-management can lead to serious and expensive medical complications. In a pilot study, adolescents suggested the use of e-technology to become more involved in the transition process. The investigators have designed and developed the YESS! game, a tool to help improve medical self-management in adolescents with chronic endocrine disorders. The hypothesis is that adolescents playing the YESS! game will show a larger increase in self-management score during the first year of transition and will have a lower drop-out rate at the adult endocrine outpatient clinic (OPC), compared to adolescents who do not play the game.

Detailed Description

Rationale: Transition from paediatric to adult endocrinology is a challenge for adolescents, families and doctors. Up to 25% of young adults with chronic endocrine disorders are lost to follow-up ('drop-out') once the young adult moves out of paediatric care. Non-attendance and sub-optimal medical self-management can lead to serious and expensive medical complications. In a pilot study, adolescents suggested the use of e-technology to become more involved in the transition process. The investigators have designed and developed the YESS! game, a tool to help improve medical self-management in adolescents with chronic endocrine disorders. The hypothesis is that adolescents playing the YESS! game will show a larger increase in self-management score during the first year of transition and will have a lower drop-out rate at the adult endocrine outpatient clinic (OPC), compared to adolescents who do not play the game.

Objective: 1.To improve medical self-management. 2.To prevent drop-out from the adult outpatient clinic. Study design: multicentre randomized controlled trial Study population: 160 transition patients from 15 to 20 years old from the participating countries Spain, The United Kingdom, Belgium and the Netherlands. Patients are diagnosed with a chronic endocrine disorder. Intervention: The study consists of 4 study arms: receiving the YESS! game and toolkit (group YT), receiving the control game and toolkit (group GT), receiving the toolkit only (group T) and receiving regular transition care (group O). Every group will receive regular transition care. The transition toolkit consists of paper cards with assignments, ideas and tips regarding medical self-management. Main study parameters: Primary outcome: the Self-management and Transition to Adulthood with Rx (=treatment) (STARx) questionnaire score 12 months after inclusion in group YT compared to group O. Secondary outcome: the STARx questionnaire score 6 months after inclusion in group YT compared to the other study groups, the STARx questionnaire score 12 months after inclusion in group YT compared to group GT and T and the drop-out rate to the adult outpatient clinic in the first year after the last visit to the paediatric endocrinologist (i.e. one year after the moment of transfer) in group YT compared to groups GT, T and O.

Nature and extent of the burden and risks associated with participation: The participants are not exposed to any risks. The YESS! and the control game are safe apps played on a mobile phone or tablet. The burden consists of filling out the STARx questionnaires and playing the YESS! or control game. The questionnaires will be filled out online at home at the start of the study and after 6 and 12 months. Every 6 months the subject has an appointment at the outpatient clinic. The participant can play the YESS! game for a maximum of 15 minutes a day to prevent game addiction. The control game could be played for an unlimited amount of time, but will unlikely cause game addiction since the game is not considered challenging and exciting enough.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
160 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Double (Care Provider, Investigator)
Primary Purpose:
Supportive Care
Official Title:
Growing up With the Young Endocrine Support System (YESS!): Innovative E-technology to Improve Transition From Paediatric to Adult Care
Anticipated Study Start Date :
Dec 1, 2020
Anticipated Primary Completion Date :
Dec 1, 2022
Anticipated Study Completion Date :
Dec 1, 2023

Arms and Interventions

Arm Intervention/Treatment
Experimental: Group YT

Group receives YESS! game and transition-toolkit

Device: YESS! game
The YESS! game is a real-life game for smartphone or tablet in which the player has to solve a mystery. The adolescent plays an active role in the course of the story. This results in an interactive experience. During the game, the adolescent is challenged with regard to self-management and responsible behaviour in general life, with parallels to medical selfmanagement and responsible behaviour. The adolescent has to decide at several different moments whether to take action or not, whether to accept help or not and whether to share (fictive) confidential information or not. Other aspects that are covered are 'taking responsibility' and 'being on time'. The choices the adolescent makes throughout the game are registered in a coded manner, for later analysis. The game is available in Dutch, English and Spanish.

Other: Transition-toolkit
The transition toolkit consists of paper cards with assignments, ideas and tips regarding medical self-management.

Experimental: Group GT

Group receives control game and transition-toolkit

Device: Snake '97
Snake '97 is a game for smartphone or tablet which is free and can be downloaded in the App Store. The game is a remake of the original snake on the mobile phone in 1997 in which the player moves the snake around and makes the snake 'consume food' (little dots) which causes the snake to grow longer. The goal is to make the snake as large as possible. The game has 12 difficulty levels.
Other Names:
  • control game
  • Other: Transition-toolkit
    The transition toolkit consists of paper cards with assignments, ideas and tips regarding medical self-management.

    Experimental: Group T

    Group receives transition-toolkit

    Other: Transition-toolkit
    The transition toolkit consists of paper cards with assignments, ideas and tips regarding medical self-management.

    No Intervention: Group O

    Group receives usual transition care

    Outcome Measures

    Primary Outcome Measures

    1. Medical self-management group YT compared to group O @12months [12 months]

      The difference in Self-management and Transition to Adulthood with Rx (treatment) (STARx) questionnaire score from baseline after 12 months in participants receiving the YESS! game and toolkit (group YT) compared to participants receiving regular care (group O).

    Secondary Outcome Measures

    1. Medical self-management group YT compared to group GT and -T @12months [12 months]

      The difference in Self-management and Transition to Adulthood with Rx (treatment) (STARx) questionnaire score from baseline after 12 months in participants receiving the YESS! game and toolkit (group YT) compared to participants receiving the control game and toolkit (group GT) and participants receiving the toolkit only (group T). Transition to Adulthood with Rx (treatment) (STARx) questionnaire score in group YT compared to group GT and group T after 12 months.

    2. Medical self-management in group YT compared to group GT, -T and -O @6months [6 months]

      The difference in Self-management and Transition to Adulthood with Rx (treatment) (STARx) questionnaire score from baseline after 6 months in participants receiving the YESS! game and toolkit (group YT) compared to participants receiving the control game and toolkit (group GT), participants receiving the toolkit only (group T) and participants receiving regular care (group O).

    3. Drop-out rate adult outpatient clinic [12 months]

      The difference in the drop-out rate to the outpatient clinic in group YT compared to group GT, group T and group O during the first year after the last visit to the paediatric endocrinologist (i.e. one year after the moment of transfer, t=24 m).

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    15 Years to 20 Years
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    Yes
    Inclusion Criteria:
    • Aged 15 to 20 years old.

    • Diagnosed with congenital adrenal hyperplasia, hypogonadotropic hypogonadism, Turner syndrome, Klinefelter syndrome, growth hormone deficiency, combined pituitary hormone deficiency, Androgen insensitivity syndrome, thyroid dysgenesis or Addison's disease

    Exclusion Criteria:
    • Lack of a mobile phone or tablet.

    • Intellectual disability or language barrier leading to inability to use the YESS! game or the control game.

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Ghent University Hospital Ghent Belgium 9000
    2 Erasmus Medical Center Rotterdam Zuid-Holland Netherlands 3015 GD
    3 Hospital Infantil Universitario Niño Jesús Madrid Spain 28009
    4 Queen Elizabeth University Hospital Glasgow United Kingdom G51 4TF
    5 Royal Hospital for Children Glasgow United Kingdom G51 4TF
    6 The Royal London Hospital (Barts Health NHS Trust) London United Kingdom E1 1BB
    7 University College London Hospital (UCL Institute of Child Health) London United Kingdom NW1 2PG

    Sponsors and Collaborators

    • dr. Laura C. G. de Graaff-Herder

    Investigators

    • Principal Investigator: Laura CG de Graaff, MD PhD, Erasmus Medical Centre

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    dr. Laura C. G. de Graaff-Herder, Principal Investigator, Erasmus Medical Center
    ClinicalTrials.gov Identifier:
    NCT04252001
    Other Study ID Numbers:
    • NL.69953.078.19
    • NL8097
    First Posted:
    Feb 5, 2020
    Last Update Posted:
    Jul 7, 2020
    Last Verified:
    Jul 1, 2020
    Individual Participant Data (IPD) Sharing Statement:
    Yes
    Plan to Share IPD:
    Yes
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    No
    Keywords provided by dr. Laura C. G. de Graaff-Herder, Principal Investigator, Erasmus Medical Center
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Jul 7, 2020